Stryker Corp. is showing no signs of slowing down deal-making after announcing a new deal to acquire HyperBranch Medical Technology, Inc. for $220m cash.
HyperBranch is a privately-held developer of proprietary polymers and cross-linked hydrogels based medical devices. It’s AdherusAutoSpray product is one of only two FDA-approved dural sealants on the market.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?